Dr. Melamud is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8270 Willow Oaks Corporate Dr
600
Fairfax, VA 22031Phone+1 703-698-9335Fax+1 703-698-0429
Education & Training
Cleveland Clinic FoundationResidency, Ophthalmology, 2002 - 2005
New York Downtown HospitalInternship, Internal Medicine, 2001 - 2002
Case Western Reserve University School of MedicineClass of 2001
Certifications & Licensure
DC State Medical License 2007 - 2026
VA State Medical License 2007 - 2026
MD State Medical License 2007 - 2025
NC State Medical License 2005 - 2008
OH State Medical License 2002 - 2008- American Board of Ophthalmology Ophthalmology
Clinical Trials
- Ocriplasmin Research to Better Inform Treatment (ORBIT) Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- Reply.Mariam Mathai, Kristen S Godwin, Julio Albarracin, Joshua Levinson, Kevin Broderick
Retina. 2023-09-01 - Incidence of Akreos AO60 intraocular lens opacification after concurrent or subsequent intraocular oil or gas use.Sneha Padidam, Nicholas Rougraff, Alexander Melamud, Joshua D Levinson
Retinal Cases & Brief Reports. 2023-04-20 - 1 citations360 DEGREE ENDOLASER VERSUS FOCAL ENDOLASER IN PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT REPAIR.Mariam Mathai, Kristen S Godwin, Julio Albarracin, Joshua Levinson, Kevin Broderick
Retina. 2022-11-01
Press Mentions
Study of Alkeus' Oral Gildeuretinol Demonstrate Significant Trend in Slowing GA Progression and Visual Function ImprovementOctober 24th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
